Transfusion Clinique et Biologique

(The TQCC of Transfusion Clinique et Biologique is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
The blood supply management amid the COVID-19 outbreak57
ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population42
The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region40
Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand25
COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?20
“Because Every Drop Counts”: Blood donation during the COVID-19 Pandemic20
Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components15
Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency13
Transfusion and sickle cell anemia in Africa13
Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation13
The chronicles of blood banking in India11
Storage of red blood cell concentrates: Clinical impact9
Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions9
Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India8
Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data8
The impact of COVID-19 on transfusion-dependent thalassemia patients of Karachi, Pakistan: A single-center experience8
The journey of blood continues7
Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity7
Recognizing the role of transfusion medicine specialist in the modern era7
Platelet transfusion practice and related transfusion reactions in a large teaching hospital7
Thirty years of hemovigilance – Achievements and future perspectives6
Variable response to therapeutic plasma exchange in pediatric anti-NMDA receptor encephalitis6
Platelet transfusion in adults: An update6
Risk factors for blood transfusion in Cesarean section: A systematic review and meta-analysis6
Post-donation information management6
Hemophilia care in Africa: Status and challenges6
Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system)6
Use of convalescent plasma in COVID-19 patients in China6
Development of a scenario-based blood bank model to maximize reducing the blood wastage6
Transfusion at the border of the “intention-to-treat”, in the very aged person and in palliative care: A debate6
Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these6
The detection, treatment of parvovirus B19 infection induced anemia in solid organ transplants: A case series and literature review of 194 patients6
Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review5
COVID-19 convalescent plasma therapy and immunodeficiency5
Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology5
Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: Bicentric study5
A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father5
A quick “Can I donate blood” self-assessment tool amid the COVID-19 outbreak5
Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants5
An overview of red blood cell and platelet alloimmunisation in transfusion5
Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation5
Review of blood donor deferral with emphasis on donor and patient safety5
Is plasma donation ethics abused?5
Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012–20165
SARS-CoV-2 infection in patients with β-thalassemia: The French experience5
Protective effect of L-carnitine on platelet apoptosis during storage of platelet concentrate5
Measuring public awareness about blood donation in Assir, South-Western Saudi Arabia5
Plasma from donors convalescent from SARS-CoV-2 infection–A matter of priorities5
Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India5
Incidence and risk predictors analysis of adverse donor reactions in whole blood donation5
Indian blood donor selection guidelines: Review in the context of the ongoing COVID-19 pandemic4
SARS COV-2- IgG antibodies in blood donors in pandemic – A game changer for policy makers4
Cost of red blood cell transfusion; evaluation in a French academic hospital4
Increasing unpaid plasma collection by blood establishments to ensure availability of plasma–derived medicinal products and blood components in Europe4
The effect of red blood cell transfusion on peripheral tissue oxygen delivery and consumption in septic patients4
Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic4
Hemolysis: Mechanism and clinico-biological consequences4
Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities4
SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward4
Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors4
A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis4
Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation4
Implementation of Low Titer Whole Blood for French overseas operations: O positive or negative products in massive hemorrhage?3
Status analysis and evaluation of the blood scrap rate from 2015–2017 for a blood center in China3
Hereditary haematologic disorders in Najaf province-Iraq3
COVID-19, transfusion, and publishing ethics3
Hepcidin-to-ferritin ratio: A potential novel index to predict iron overload-liver fibrosis in ß-thalassemia major3
Transfusion safety in the Maghreb region3
Epidemiological aspects and molecular characterization of the hepatitis B virus among blood donors in Lubumbashi, Democratic Republic of Congo3
Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light3
Mesenchymal – Stem and non-Stem – Cells: The name of the rose3
Covid 19 vaccination: Latest guidelines on blood donor deferral in India3
International collaboration for blood safety: The French—African experience3
Nitric oxide donors offer protection to RBC from storage lesion3
How do I/we forecast tomorrow’s transfusion? A focus on recipients’ profiles3
Positive direct antiglobulin tests in cancer patients hospitalized with COVID-19: A brief report from India3
Drug-induced immune hemolytic anemia investigation: Comparison between tube test and microcolumn agglutination (gel test) for the detection of drug-dependent antibodies in the presence of soluble drug3
Viral metagenomics in Brazilian multiply transfused patients with sickle cell disease as an indicator for blood transfusion safety3
Clinical performance evaluation of Elecsys HIV Duo, Anti-HCV II, HBsAg II, Anti-HBc II, and Syphilis assays for routine screening of first-time blood donor samples at a French blood donation center3
Ethics in transfusion medicine: Are the intricate layers of ethics all universal? A global view3
COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period3
Deciphering the reasons for milky-white blood donor plasma2
Transfusion medicine: Overtime paradigm changes and emerging paradoxes2
ABO blood group should be considered and reported when red blood cell exchange transfusion is used to treat Plasmodium falciparum Malaria patients2
Auto-anticorps anti-interférons de type I et COVID-19 sévère2
How do we forecast tomorrow’s transfusion? Prehospital transfusion2
Extended blood group phenotyping of donors from the lower and middle Himalayan region of Uttarakhand India: A pilot study2
Iron-deficiency among blood donors: Donors’ opinion on iron supplementation strategy2
Prevalence of HEV RNA in Croatian blood donors2
Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma2
Cytokine dependent hematopoietic cell linker (CLNK) is highly elevated in blood transfusion dependent beta-thalassemia major patients2
The evolution of xenotransfusions through the ages2
Utilizing SPIKES protocol for breaking bad news to sero-reactive blood donors2
Improved neural network for predicting blood donations based on two emergent factors2
Transfusion management of a Chinese pregnant woman with RHD*DEL1 allele2
The interphase between immunoglobulin, the plasma industry and the public health, managing a finite resource2
Pre-hospital transfusion of post-traumatic hemorrhage: Medical and regulatory aspects2
COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits2
O-negative blood shortage management in a university hospital: Impact of transfusing RhD-positive red blood cells to RhD-negative patients2
Design and introduction of a rational mechanical eluting system for leukocyte recovery from leukoreduction filters: A cell differential approach2
How do we forecast tomorrow’s transfusion: The future of hematopoietic stem cell donation2
Trends in serological markers of transfusion transmissible infections in blood donations at the Bamenda Hospital-based Blood Service, Cameroon2
Retrospective analysis of molecular biology mechanism of ABO blood group typing discrepancy among blood donors in Jinan blood station2
Deferral of men who have sex with men from blood donation: Policy and change2
Red-cell alloimmunization profile in multi transfused patients: Findings and insights of a blood transfusion service2
Challenges in transfusion-transmitted infection screening in Sub-Saharan Africa2
Abnormal hemoglobin H band in myelodysplastic syndromes (MDS): A case report2
Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic2
Real-world data from India on clinical practices in the management of autoimmune haemolytic anaemia: A survey-based cross-sectional assessment2
Effective and safe off-label use of caplacizumab treatment in a middle-aged obese male2
Transfusional iron overload in patients with myelodysplastic syndromes: A 10-year retrospective survey from a French general hospital2
Clinical impact of rotational thromboelastometry in cardiac surgery2
Positive direct antiglobulin test in COVID-19 patients: Decision-making process2
Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 20212
Delayed adverse reaction in donors after whole blood donation: Is it a matter of concern?1
COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors1
Delayed haemolytic transfusion reaction due to Kidd antibodies1
Evaluation of beta-thalassemia in the fetus through cffDNA with multiple polymorphisms as a haplotype in the beta-globin gene1
There is an urgent need to adopt a pull-flow logic for the supply of RBCs to meet patients’ needs: A single center study1
Comparative evaluation of DTT treated ABO isoagglutinin titres performed by two methods with solid phase red cell adhesion (SPRCA) titres1
Don’t neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia1
L-34 PBM - Gestion Personnalisée du Capital Sanguin du Patient en Péri-opératoire1
Utilisation patterns of group O red blood cell transfusion by ABO and D non-identical recipients in large academic hospital1
The appropriateness of platelet transfusions in hematological patients and the potential for improvement1
Transfusion-related respiratory complications in intensive care: A diagnosis challenge1
Renaissance in usage of excess plasma in blood banks1
Averting transfusion related catastrophe during blood administration: Backing transfusion bioethics1
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma1
P-08 Vers un système d[StQuote]hémovigilance efficace et pérenne en Afrique francophone1
A case of severe hemolytic disease of newborn due to alloimmunization in primigravida1
Role of Therapeutic Plasma Exchange in managing complement mediated thrombotic microangiopathy  – Case series1
Positive direct antiglobulin tests in cancer patients on immune checkpoint inhibitors: A case series from India1
What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis1
Inactivation des pathogènes par le procédé Intercept® dans les concentrés plaquettaires : bilan de 3 ans de généralisation en France1
Covid-19 convalescent plasma and SARS-CoV-2 viral variants1
Covid-19 induced blood supply shortage: A Tunisian blood deposit perspective1
Serological and molecular analysis of the B(A) subtype in China—A systematic review1
How do we forecast tomorrow’s transfusion? — Next generation transfusion practices to improve recipient safety1
Effect of vibration of the vortex mixer on the red blood cells1
Reporting an abrupt-onset persistent hypotensive transfusion reaction in an Indian female patient1
Significant decrease in the transfusion rates during the COVID-19 pandemic in the North East of Iran1
Prevalence and factors associated with vasovagal reaction among whole blood donors in hospital Universiti Sains Malaysia1
Accurate detection of reemergent anti-donor ABO antibody is crucial for safe transfusion in ABO major incompatible HSCT patient after achieved the stages of full switch to donor type1
Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence1
Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!1
Homing of granulocytes transfused in perineal cellulitis in a RAC2 deficiency child monitored by chimerism quantification methods1
Platelet transfusion therapy in the management of dengue patients: Role of fundus examination1
CL-15 Evaluation du risque résiduel de contamination bactérienne dans les concentrés plaquettaires traités par inactivation des pathogènes en France1
Prenatal RHD genotyping in Croatia: preliminary results1
Advancing blood transfusion safety using molecular detection in the country of Georgia1
A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India1
Determination of Rh type and gender using circulating cell-free fetal DNA in early pregnancy of Rh negative women in turkey1
Transfusional iron overload in heavily transfused patients: Real-life data from a 10-year retrospective study of 611 cases managed in a French general hospital1
Patient blood management in adults and children: What have we achieved, and what still needs to be addressed?1
Blood inventory management strategies to ensure adequacy of packed red blood cell stock1
What is the optimal pretransfusion testing interval for multi-transfused patients? The University Hospital of Brest experience1
Impact of blood donor characteristics on quality of packed red blood cell concentrates1
Reverse algorithm for screening of syphilis and trends in prevalence among blood donors in Coastal Karnataka1
Transfusion management of Africans with RHD variants in China1
Significance of mandating a dedicated hemovigilance nurse and objectification of ‘imputability’ levels. Experience from a hospital-based blood centre in India1
Estimation of genetic variation in the Secretor and Lewis genes in Iranian hospitalized children1
Supporting Garraud – and protecting transfusion1
How do we forecast tomorrow’s transfusion? Applying social science approaches to meet tomorrow’s transfusion needs: Blood donors and donation1
How do I/we forecast tomorrows’ transfusion: Blood components1
Carence en fer chez les donneurs de sang en France : état des lieux et perspectives de prévention1
How do I/We forecast tomorrow’s transfusion? A series of experts’ proposals for changes in transfusion medicine1
In vitro characteristics of cryopreserved platelet concentrates reconstituted by fresh frozen or lyophilized plasma1
The Indian “blood storage centre” model for the provision of safe blood towards obstetric care in the remote regions of Uttarakhand1
Détection de mutations de résistance du VIH aux antirétroviraux : vers un dépistage rapide pré-thérapeutique ?1
Maîtrise du risque transfusionnel en ES : réflexion sur la démarche a priori des risques1
P-23 Un cas d’EIR grave, mais surtout de diagnostic rebelle1
How do we forecast tomorrows’ transfusion: Non-transfusional hemotherapy1
Strawberry milky-white blood donor's plasma: signaling uncontrolled diabetic lipemia1
History of blood ‘the ' unites us all1
Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor1
Modèle de transfusion in vitro pour étudier les globules rouges1
Regulation of blood services in Africa1
Red cell alloimmunization in thalassaemia patients in India: Causes and mitigation strategies1
The European health data space proposal: An opportunity for improved blood donor protection and transfusion recipient care1
Les limites d’une approche principiste dans l’éthique du don d’éléments et produits du corps humain. À propos d’exemples1
The role of funduscopy in severe thrombocytopenia: A prospective study1
Does intraoperative transfusion during total knee arthroplasty reduce the need for transfusion after surgery?: A preliminary retrospective cohort study1
The impact of a closed-loop electronic blood transfusion system on transfusion errors and staff time in a children's hospital1
Building capacities in research for blood services in Africa1
Transient pseudothrombocytopenia (PTCP) in the neonate due to the mother1
Factors influencing the return of inactive blood donors in a Cameroonian blood bank1
The best use of the French donors’ gift – Continuing an ethical tradition1
Blood-Type-A is a COVID-19 infection and hospitalization risk in a Turkish cohort1
Towards equitable and sustainable availability of blood products in Zimbabwe: An analysis of strengths, weaknesses, opportunities and challenges1
How do we forecast tomorrow’s transfusion: Infectious safety?1
First successful pregnancy outcome after twelve abortions in a Tunisian-woman with the rare p phenotype1
The AfSBT Step-wise Accreditation program: Improving the quality in the African blood services1
Infectious diseases and the impact on transfusion medicine: A historical review and lessons for the future1
L’éthique du don s’applique-t-elle de la même façon à tous les éléments du corps humain ?1
CL-10 Développement d’un outil informatique de surveillance des PSL présents dans les Dépôts d’Urgence Vitale de la région Occitanie0
Les nouveaux systèmes de groupes sanguins érythrocytaires découverts en 2020 : CTL2, ABCC4, MAM, EMM et ABCC10
CL-17 Réalisation des prélèvements pour phénotypage érythrocytaire : une nouvelle enquête multicentrique et des pistes pour aller plus loin0
L-62 Transfusion et patients COVID-19 au cours de la 1ère vague0
P-38 Fiabilité des hémoglobinomètres utilisés au Centre National de Transfusion Sanguine d’Abidjan, Côte d’Ivoire0
Comparaison qualitative des concentrés plaquettaires traités par Mirasol et Intercept0
Incident grave de la chaîne : un risque minimisé par la procédure d’urgence vitale de l’EFS0
Place de l’EDA élargi et de la recherche d’AF dans l’exploration d’une AHAI0
Cadre d’action pour la promotion de l’accès universel à des produits sanguins sûrs dans la Région africaine de l’OMS0
Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol0
Hyper-hémolyse post-transfusionnelle retardée chez le drépanocytaire : à propos d’un cas0
P-50 Gestion des CGR irradiés en HFNO0
La possibilité d’un système expert dans la déclaration des EIR0
Editorial Board0
Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis0
L-61 Transfusion sanguine en Opération Extérieure : retour d’expérience d’une mission de l’opération Barkhane0
Les vésicules extracellulaires dérivées des plaquettes sont impliquées dans la présentation des antigènes via leur MHC de classe I0
L-54 Le « patient blood management » dans la démarche RAAC0
Vers une meilleure compréhension des microvésicules dans les concentrés érythrocytaires0
P-54 Le protocole transfusionnel donneur unique (PDU) en néonatalogie : vision du néonatalogiste0
Profils éléctrophorétiques des protéines des donneurs de sang du CHU d’Oran0
L-28 L’évaluation de la formation : une nécessité pour tous0
P-59 Formateur une passion en mouvement0
RAI 21 jours, aide à la prescription. Expérience aixoise0
Groupage sanguin, redondances et pertinence0
Formation des internes à la sécurité transfusionnelle et aux bonnes pratiques de prescription des PSL : bilan du Groupe des hémobiologistes et correspondants d’hémovigilance (GHCOH)0
Validation des analyses d’immuno-hématologie « au fil de l’eau »0
Validation de la préparation de MCP-IA DS par centrifugation/séparation avec CompoStop™ CI0
No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis0
Revue qualité produits : vers un outil simple et efficace0
P-18 Anticorps anti-MNS4 non hémolysant chez une multipare0
Groupe A faible, Para-Bombay et Bombay Réunion : quelles techniques simples au laboratoire pour orienter le diagnostic et le conseil transfusionnel ?0
L-51 Gestion de l’hémorragie du post-partum0
Apport de la géomatique dans l’optimisation de la filière sang rare et phénotypes d’intérêt0
L-18 Les erreurs de receveurs et de patients destinataires de produits sanguins labiles (PSL) : données nationales et européennes0
Expression of microRNAs during apheresis platelet storage up to day 14 in a blood bank in China0
P-17 Le TRALI (Transfusion Related Lung Injury) à l’unité d’hémovigilance du CRTS de Sfax, Tunisie0
Therapeutic plasma exchange as a treatment modality for steroid refractory acute disseminated encephalomyelitis – A case report0
P-46 Risque résiduel de transmission du virus de l’hépatite C au Centre de Transfusion Sanguine de Yamoussoukro, Côte d’Ivoire, de 2017 à 20200
La transfusion au Maroc : mise au point sur la réglementation0
P-61 Ethique transfusionnelle : quelle décision prendre ?0
CL-05 Automatisation du titrage des anticorps anti-A et anti-B naturels et immuns0
Étiologie des incompatibilités érythrocytaires : à propos de 10 649 cas0
Ouverture au don des HSH : état des lieux et perspectives0
Évaluation des anomalies liées à la non-utilisation du logiciel de gestion des donneurs en collecte mobile : bilan de 2 mois de prélèvements0
Audit des transporteurs de produits sanguins labiles des établissements de santé de la région Centre-Val de Loire au 01/01/20200
What has changed after the COVID-19 pandemic in the publication process? A look-back to “Transfusion clinique et biologique”0
Évaluation des MCP-IA traités avec un dispositif intégrant un CAD modifié0
Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence0
Traitement du purpura thrombotique thrombocytopénique auto-immun : un tournant décisif0
P-03 La formation continue en sécurité transfusionnelle au CHU de Dijon : Comment l’améliorer ?0
Quelle prise en charge pour les donneurs de sang suspectés de présenter un phénotype McLeod lors de la Qualification Biologique du Don ?0
L-27 L’importance de l’animation de la formation0
Table des matières0
L-10 Approvisionnement des Dépôts de Délivrance en EFS Occitanie0
Intraoperative and immediate postoperative transfusion: Clinical-hematological profile of transfunded patients in a university hospital0